Biologics Market Research Report by Product (Cellular Based Biologics, Gene Based Biologics, and Monoclonal Antibodies), by Application (Autoimmune Diseases, Cancer, and Infectious Diseases), by Region (Americas, Asia-Pacific, and Europe, Middle East & Af

Biologics Market Research Report by Product (Cellular Based Biologics, Gene Based Biologics, and Monoclonal Antibodies), by Application (Autoimmune Diseases, Cancer, and Infectious Diseases), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

The Global Biologics Market size was estimated at USD 247.82 billion in 2020 and expected to reach USD 259.87 billion in 2021, at a CAGR 5.19% to reach USD 335.91 billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Biologics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies, Recombinant Hormones/Proteins, and Vaccines. The Monoclonal Antibodies is further studied across Diagnostic and Therapeutic. The Diagnostic is further studied across Biochemical Analysis and Diagnostic Imaging. The Therapeutic is further studied across Direct MAB Agents and Targeting MAB Agents.

Based on Application, the market was studied across Autoimmune Diseases, Cancer, Infectious Diseases, and Rare Diseases.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biologics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biologics Market, including AbbVie Inc., Allergan, Amgen Inc, Apogenix, AstraZeneca, Bayer AG, Biocon, BioMarin Pharmaceutical, Celltrion, Eli Lilly and Company, F. Hoffmann-La Roche AG, Gangagen, GlaxoSmithKline PLC, GSK group of companies, Johnson & Johnson, Medexus Pharma, Merck & Co., Novo Nordisk AS, Pfizer Inc., Precision Biologics, Inc., Samsung BioLogics, Sanofi SA, Theratome Bio, Tubulis Technologies, and Vaximm.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biologics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biologics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biologics Market?
4. What is the competitive strategic window for opportunities in the Global Biologics Market?
5. What are the technology trends and regulatory frameworks in the Global Biologics Market?
6. What is the market share of the leading vendors in the Global Biologics Market?
7. What modes and strategic moves are considered suitable for entering the Global Biologics Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Attractive investment in the market from players across value chain
5.2.2. Rising prevalence of chronic diseases
5.2.3. Patent loss of leading biologic drugs
5.2.4. Availability of advanced diagnostics and rising government initiatives in healthcare
5.3. Restraints
5.3.1. Stringent regulatory process coupled with high capital investment
5.4. Opportunities
5.4.1. Higher acceptability for innovative therapies
5.4.2. Technological advancements in research and development across the globe
5.5. Challenges
5.5.1. Tightly controlled atmospheric conditions and maintained production process
5.5.2. Cost associated with access of biologics
6. Biologics Market, by Product
6.1. Introduction
6.2. Cellular Based Biologics
6.3. Gene Based Biologics
6.4. Monoclonal Antibodies
6.4.1. Diagnostic
6.4.1.1. Biochemical Analysis
6.4.1.2. Diagnostic Imaging
6.4.2. Therapeutic
6.4.2.1. Direct MAB Agents
6.4.2.2. Targeting MAB Agents
6.5. Recombinant Hormones/Proteins
6.6. Vaccines
7. Biologics Market, by Application
7.1. Introduction
7.2. Autoimmune Diseases
7.3. Cancer
7.4. Infectious Diseases
7.5. Rare Diseases
8. Americas Biologics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Biologics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Biologics Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. AbbVie Inc.
12.2. Allergan
12.3. Amgen Inc
12.4. Apogenix
12.5. AstraZeneca
12.6. Bayer AG
12.7. Biocon
12.8. BioMarin Pharmaceutical
12.9. Celltrion
12.10. Eli Lilly and Company
12.11. F. Hoffmann-La Roche AG
12.12. Gangagen
12.13. GlaxoSmithKline PLC
12.14. GSK group of companies
12.15. Johnson & Johnson
12.16. Medexus Pharma
12.17. Merck & Co.
12.18. Novo Nordisk AS
12.19. Pfizer Inc.
12.20. Precision Biologics, Inc.
12.21. Samsung BioLogics
12.22. Sanofi SA
12.23. Theratome Bio
12.24. Tubulis Technologies
12.25. Vaximm
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL BIOLOGICS MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 3. GLOBAL BIOLOGICS MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 5. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2026
FIGURE 7. GLOBAL BIOLOGICS MARKET SIZE, BY CELLULAR BASED BIOLOGICS, 2018-2026 (USD BILLION)
FIGURE 8. GLOBAL BIOLOGICS MARKET SIZE, BY CELLULAR BASED BIOLOGICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 9. GLOBAL BIOLOGICS MARKET SIZE, BY GENE BASED BIOLOGICS, 2018-2026 (USD BILLION)
FIGURE 10. GLOBAL BIOLOGICS MARKET SIZE, BY GENE BASED BIOLOGICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 11. GLOBAL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2026 (USD BILLION)
FIGURE 12. GLOBAL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 13. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2026 (USD BILLION)
FIGURE 14. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 15. GLOBAL BIOLOGICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2018-2026 (USD BILLION)
FIGURE 16. GLOBAL BIOLOGICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 17. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2026 (USD BILLION)
FIGURE 18. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 19. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2026 (USD BILLION)
FIGURE 20. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 21. GLOBAL BIOLOGICS MARKET SIZE, BY DIRECT MAB AGENTS, 2018-2026 (USD BILLION)
FIGURE 22. GLOBAL BIOLOGICS MARKET SIZE, BY DIRECT MAB AGENTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 23. GLOBAL BIOLOGICS MARKET SIZE, BY TARGETING MAB AGENTS, 2018-2026 (USD BILLION)
FIGURE 24. GLOBAL BIOLOGICS MARKET SIZE, BY TARGETING MAB AGENTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 25. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT HORMONES/PROTEINS, 2018-2026 (USD BILLION)
FIGURE 26. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT HORMONES/PROTEINS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 27. GLOBAL BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2026 (USD BILLION)
FIGURE 28. GLOBAL BIOLOGICS MARKET SIZE, BY VACCINES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 29. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 30. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2026
FIGURE 32. GLOBAL BIOLOGICS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2026 (USD BILLION)
FIGURE 33. GLOBAL BIOLOGICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 34. GLOBAL BIOLOGICS MARKET SIZE, BY CANCER, 2018-2026 (USD BILLION)
FIGURE 35. GLOBAL BIOLOGICS MARKET SIZE, BY CANCER, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 36. GLOBAL BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD BILLION)
FIGURE 37. GLOBAL BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 38. GLOBAL BIOLOGICS MARKET SIZE, BY RARE DISEASES, 2018-2026 (USD BILLION)
FIGURE 39. GLOBAL BIOLOGICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 40. AMERICAS BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 41. ARGENTINA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 42. BRAZIL BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. CANADA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. MEXICO BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. UNITED STATES BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. ASIA-PACIFIC BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. AUSTRALIA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. CHINA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. INDIA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. INDONESIA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. JAPAN BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. MALAYSIA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. PHILIPPINES BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. SINGAPORE BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. SOUTH KOREA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. TAIWAN BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. THAILAND BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. FRANCE BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. GERMANY BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. ITALY BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. NETHERLANDS BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. QATAR BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. RUSSIA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. SAUDI ARABIA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 66. SOUTH AFRICA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 67. SPAIN BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 68. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 69. UNITED KINGDOM BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 70. GLOBAL BIOLOGICS MARKET: FPNV POSITIONING MATRIX
FIGURE 71. GLOBAL BIOLOGICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOLOGICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL BIOLOGICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL BIOLOGICS MARKET SIZE, BY CELLULAR BASED BIOLOGICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL BIOLOGICS MARKET SIZE, BY GENE BASED BIOLOGICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL BIOLOGICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL BIOLOGICS MARKET SIZE, BY DIRECT MAB AGENTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL BIOLOGICS MARKET SIZE, BY TARGETING MAB AGENTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT HORMONES/PROTEINS, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL BIOLOGICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL BIOLOGICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL BIOLOGICS MARKET SIZE, BY CANCER, BY REGION, 2018-2026 (USD BILLION)
TABLE 19. GLOBAL BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2026 (USD BILLION)
TABLE 20. GLOBAL BIOLOGICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2026 (USD BILLION)
TABLE 21. AMERICAS BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. ARGENTINA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. BRAZIL BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. CANADA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. MEXICO BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. UNITED STATES BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. ASIA-PACIFIC BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. AUSTRALIA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. CHINA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. INDIA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. INDONESIA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. JAPAN BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. MALAYSIA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. PHILIPPINES BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. SINGAPORE BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. SOUTH KOREA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. TAIWAN BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. THAILAND BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. FRANCE BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. GERMANY BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. ITALY BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. NETHERLANDS BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. QATAR BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. RUSSIA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. SAUDI ARABIA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. SOUTH AFRICA BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 48. SPAIN BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 49. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 50. UNITED KINGDOM BIOLOGICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 51. GLOBAL BIOLOGICS MARKET: SCORES
TABLE 52. GLOBAL BIOLOGICS MARKET: BUSINESS STRATEGY
TABLE 53. GLOBAL BIOLOGICS MARKET: PRODUCT SATISFACTION
TABLE 54. GLOBAL BIOLOGICS MARKET: RANKING
TABLE 55. GLOBAL BIOLOGICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 56. GLOBAL BIOLOGICS MARKET: MERGER & ACQUISITION
TABLE 57. GLOBAL BIOLOGICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 58. GLOBAL BIOLOGICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 59. GLOBAL BIOLOGICS MARKET: INVESTMENT & FUNDING
TABLE 60. GLOBAL BIOLOGICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 61. GLOBAL BIOLOGICS MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook